Daily News Podcast

FDA approval for 2 HIV drugs


 

The FDA approves the once-daily oral drugs Delstrigo and Pifeltro for HIV-1 infection. Also today, emicizumab beats factor VIII prophylaxis by a wide margin, orodental issues are often associated with facial port-wine stains, and epilepsy often accompanies congenital Zika infections. Subscribe to the MDedge Daily News wherever you get your podcasts.
Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Open AAA and peripheral bypass surgery patients among the highest users of post-acute care
MDedge Infectious Disease
Sleepio app tied to reducing insomnia, depression
MDedge Infectious Disease
5 digital HIPAA myths
MDedge Infectious Disease
Screen for cervical cancer based on age, risk
MDedge Infectious Disease
Is it time for PCPs to take over chronic HCV?
MDedge Infectious Disease
Rivaroxaban data abound at ESC 2018
MDedge Infectious Disease
New MI definition for infarction vs injury
MDedge Infectious Disease
Lorcaserin shows cardiovascular safety
MDedge Infectious Disease
Lung function decline linked to cardiovascular risk
MDedge Infectious Disease
Rivaroxaban beats aspirin for VTE
MDedge Infectious Disease